CROP Infrastructure Corp. (CSE:CROP, OTC:CRXPF) (“CROP”) announced today its California tenant has received additional lab results from its first crop.
CROP Infrastructure Corp. (CSE:CROP, OTC:CRXPF) (“CROP”) announced today its California tenant has received additional lab results from its first crop. The first sample of dried 707 OG cannabis flower was submitted to Humboldt Quality Assurance Laboratory for analysis on September 14, 2018. The Company has been informed that samples of Platinum OG Kush have been submitted for additional testing.
The 707 OB sample has received a Tetrahydrocannabolic Acid (‘THCA’) result of 23.9% and passed all tests for microbial impurities and detectable pesticides. THCA is not directly used, but its presence is commonly analyzed when cannabis or hemp-based products are screened for THC. State testing is still pending.
CROP Infrastructure Director and CEO, Michael Yorke, stated: “Following our CROP SAFE method and SOP’s, CROP is pleased to announce that our tenant has achieved a concentration of 23.9% THCa. 23.9% THCa commands a higher market value and is considered premium quality.”
Crop Infrastructure Corp. is publicly listed on the Canadian Securities Exchange and trades under the symbol “CROP” and in the US under the symbol “CRXPF”. CROP is primarily engaged in the business of investing, constructing, owning and leasing greenhouse projects as part of the provision of turnkey real estate solutions for lease-to-licensed cannabis producers and processors offering best-in-class operations. The Company’s portfolio of projects includes cultivation properties in California and Washington State, Nevada, Italy, Jamaica and a joint venture on West Hollywood and San Bernardino dispensary applications. CROP has developed a portfolio of assets including Canna Drink a cannabis infused functional beverage, US and Italian distribution rights to over 55 cannabis topical products and a portfolio of 16 Cannabis brands.
Disclaimer for Forward-Looking Information
Certain statements in this press release related to the Offering, the securities issuable thereunder and the Transaction are forward-looking statements and are prospective in nature. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect.These statements generally can be identified by the use of forward-looking words such as “may”, “should”, “could”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe” or “continue”, or the negative thereof or similar variations. Forward-looking statements in this news release include statements regarding the expected yield from The Humboldt Property; the technological effects of The Humboldt Property on production; the intention to expand its portfolio; and execute on its business plan. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding the regulatory and legal framework regarding the cannabis industry in general among all levels of government and zoning; risks associated with applicable securities laws and stock exchange rules relating to the cannabis industry; risks associated with maintaining its interests in its various assets; the ability of the Company to finance operations and execute its business plan and other factors beyond the control of the Company. Such forward-looking statements should therefore be construed in light of such factors, and the Company is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
The CSE has not reviewed, approved or disapproved the content of this press release.
For further information: Company Contact: Michael Yorke – CEO & Director, E-mail: firstname.lastname@example.org, Website: http://www.cropcorp.com, Phone: +1-(604)-484-4206